Getting your player ready...
WASHINGTON — The Senate Appropriations Committee has approved legislation to prohibit drug companies from paying generic-drug makers to delay bringing less costly products to market. The measure is in a spending bill that funds the Federal Trade Commission’s budget.
Denver Post staff and wire reports
